nodes	percent_of_prediction	percent_of_DWPC	metapath
Ammonium lactate—Skin hyperpigmentation—Thiotepa—sarcoma	0.0569	0.0569	CcSEcCtD
Ammonium lactate—Extravasation—Thiotepa—sarcoma	0.0388	0.0388	CcSEcCtD
Ammonium lactate—Extravasation—Dactinomycin—sarcoma	0.0385	0.0385	CcSEcCtD
Ammonium lactate—Petechiae—Mitoxantrone—sarcoma	0.0355	0.0355	CcSEcCtD
Ammonium lactate—Extravasation—Vincristine—sarcoma	0.0344	0.0344	CcSEcCtD
Ammonium lactate—Extravasation—Mitoxantrone—sarcoma	0.0335	0.0335	CcSEcCtD
Ammonium lactate—Skin exfoliation—Thiotepa—sarcoma	0.0323	0.0323	CcSEcCtD
Ammonium lactate—Phlebitis—Dactinomycin—sarcoma	0.0283	0.0283	CcSEcCtD
Ammonium lactate—Extravasation—Etoposide—sarcoma	0.0279	0.0279	CcSEcCtD
Ammonium lactate—Venous thrombosis—Epirubicin—sarcoma	0.0253	0.0253	CcSEcCtD
Ammonium lactate—Phlebitis—Mitoxantrone—sarcoma	0.0246	0.0246	CcSEcCtD
Ammonium lactate—Venous thrombosis—Doxorubicin—sarcoma	0.0234	0.0234	CcSEcCtD
Ammonium lactate—Skin exfoliation—Etoposide—sarcoma	0.0232	0.0232	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Epirubicin—sarcoma	0.0229	0.0229	CcSEcCtD
Ammonium lactate—Skin hyperpigmentation—Doxorubicin—sarcoma	0.0212	0.0212	CcSEcCtD
Ammonium lactate—Phlebitis—Etoposide—sarcoma	0.0205	0.0205	CcSEcCtD
Ammonium lactate—Stinging—Epirubicin—sarcoma	0.0168	0.0168	CcSEcCtD
Ammonium lactate—Petechiae—Epirubicin—sarcoma	0.0166	0.0166	CcSEcCtD
Ammonium lactate—Extravasation—Epirubicin—sarcoma	0.0156	0.0156	CcSEcCtD
Ammonium lactate—Stinging—Doxorubicin—sarcoma	0.0156	0.0156	CcSEcCtD
Ammonium lactate—Petechiae—Doxorubicin—sarcoma	0.0153	0.0153	CcSEcCtD
Ammonium lactate—Erythema—Thiotepa—sarcoma	0.0148	0.0148	CcSEcCtD
Ammonium lactate—Erythema—Dactinomycin—sarcoma	0.0147	0.0147	CcSEcCtD
Ammonium lactate—Extravasation—Doxorubicin—sarcoma	0.0145	0.0145	CcSEcCtD
Ammonium lactate—Skin exfoliation—Epirubicin—sarcoma	0.013	0.013	CcSEcCtD
Ammonium lactate—Erythema—Mitoxantrone—sarcoma	0.0128	0.0128	CcSEcCtD
Ammonium lactate—Skin exfoliation—Doxorubicin—sarcoma	0.012	0.012	CcSEcCtD
Ammonium lactate—Infection—Thiotepa—sarcoma	0.012	0.012	CcSEcCtD
Ammonium lactate—Infection—Dactinomycin—sarcoma	0.0119	0.0119	CcSEcCtD
Ammonium lactate—Skin disorder—Thiotepa—sarcoma	0.0117	0.0117	CcSEcCtD
Ammonium lactate—Phlebitis—Epirubicin—sarcoma	0.0115	0.0115	CcSEcCtD
Ammonium lactate—Eczema—Epirubicin—sarcoma	0.011	0.011	CcSEcCtD
Ammonium lactate—Infection—Vincristine—sarcoma	0.0106	0.0106	CcSEcCtD
Ammonium lactate—Phlebitis—Doxorubicin—sarcoma	0.0106	0.0106	CcSEcCtD
Ammonium lactate—Infection—Mitoxantrone—sarcoma	0.0104	0.0104	CcSEcCtD
Ammonium lactate—Pain—Thiotepa—sarcoma	0.0103	0.0103	CcSEcCtD
Ammonium lactate—Pain—Dactinomycin—sarcoma	0.0103	0.0103	CcSEcCtD
Ammonium lactate—Eczema—Doxorubicin—sarcoma	0.0102	0.0102	CcSEcCtD
Ammonium lactate—Skin disorder—Mitoxantrone—sarcoma	0.0101	0.0101	CcSEcCtD
Ammonium lactate—Body temperature increased—Thiotepa—sarcoma	0.00955	0.00955	CcSEcCtD
Ammonium lactate—Body temperature increased—Dactinomycin—sarcoma	0.00948	0.00948	CcSEcCtD
Ammonium lactate—Pain—Vincristine—sarcoma	0.00916	0.00916	CcSEcCtD
Ammonium lactate—Dry skin—Epirubicin—sarcoma	0.00907	0.00907	CcSEcCtD
Ammonium lactate—Pain—Mitoxantrone—sarcoma	0.00892	0.00892	CcSEcCtD
Ammonium lactate—Infection—Etoposide—sarcoma	0.00862	0.00862	CcSEcCtD
Ammonium lactate—Body temperature increased—Vincristine—sarcoma	0.00847	0.00847	CcSEcCtD
Ammonium lactate—Skin disorder—Etoposide—sarcoma	0.00843	0.00843	CcSEcCtD
Ammonium lactate—Dry skin—Doxorubicin—sarcoma	0.0084	0.0084	CcSEcCtD
Ammonium lactate—Body temperature increased—Mitoxantrone—sarcoma	0.00825	0.00825	CcSEcCtD
Ammonium lactate—Rash—Thiotepa—sarcoma	0.00762	0.00762	CcSEcCtD
Ammonium lactate—Dermatitis—Thiotepa—sarcoma	0.00761	0.00761	CcSEcCtD
Ammonium lactate—Rash—Dactinomycin—sarcoma	0.00756	0.00756	CcSEcCtD
Ammonium lactate—Pain—Etoposide—sarcoma	0.00742	0.00742	CcSEcCtD
Ammonium lactate—Body temperature increased—Etoposide—sarcoma	0.00686	0.00686	CcSEcCtD
Ammonium lactate—Rash—Vincristine—sarcoma	0.00676	0.00676	CcSEcCtD
Ammonium lactate—Dermatitis—Vincristine—sarcoma	0.00675	0.00675	CcSEcCtD
Ammonium lactate—Rash—Mitoxantrone—sarcoma	0.00658	0.00658	CcSEcCtD
Ammonium lactate—Dermatitis—Mitoxantrone—sarcoma	0.00657	0.00657	CcSEcCtD
Ammonium lactate—Erythema—Epirubicin—sarcoma	0.00596	0.00596	CcSEcCtD
Ammonium lactate—Erythema—Doxorubicin—sarcoma	0.00552	0.00552	CcSEcCtD
Ammonium lactate—Rash—Etoposide—sarcoma	0.00547	0.00547	CcSEcCtD
Ammonium lactate—Dermatitis—Etoposide—sarcoma	0.00547	0.00547	CcSEcCtD
Ammonium lactate—Infection—Epirubicin—sarcoma	0.00483	0.00483	CcSEcCtD
Ammonium lactate—Skin disorder—Epirubicin—sarcoma	0.00473	0.00473	CcSEcCtD
Ammonium lactate—Infection—Doxorubicin—sarcoma	0.00447	0.00447	CcSEcCtD
Ammonium lactate—Skin disorder—Doxorubicin—sarcoma	0.00437	0.00437	CcSEcCtD
Ammonium lactate—Pain—Epirubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Ammonium lactate—Pain—Doxorubicin—sarcoma	0.00385	0.00385	CcSEcCtD
Ammonium lactate—Body temperature increased—Epirubicin—sarcoma	0.00385	0.00385	CcSEcCtD
Ammonium lactate—Body temperature increased—Doxorubicin—sarcoma	0.00356	0.00356	CcSEcCtD
Ammonium lactate—Rash—Epirubicin—sarcoma	0.00307	0.00307	CcSEcCtD
Ammonium lactate—Dermatitis—Epirubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Ammonium lactate—Rash—Doxorubicin—sarcoma	0.00284	0.00284	CcSEcCtD
Ammonium lactate—Dermatitis—Doxorubicin—sarcoma	0.00284	0.00284	CcSEcCtD
